Erratum: The EDA-containing cellular fibronectin induces epithelial mesenchymal transition in lung cancer cells through integrin α9β1-mediated activation of PI3-K /Akt and Erk1/2 (Carcinogenesis (2014) 35: 1 (184–191) DOI: 10.1093/carcin/bgt276);The EDA-containing cellular fibronectin induces epithelial-mesenchymal transition in lung cancer cells through integrin α9β1-mediated activation of PI3-K/AKT and Erk1/2

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 184-191

  Sun, Xiaojuan ^a,b   Fa, Pingping ^c   Cui, Zhiwen ^c   Xia, Ye ^c   Sun, Liang ^a   Li, Zesong ^a   Tang, Aifa ^a   Gui, Yaoting ^c   Cai, Zhiming ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA SMOOTH MUSCLE ACTIN; ALPHA5 INTEGRIN; ALPHA9BETA1 INTEGRIN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; EXTRA DOMAIN A PROTEIN; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; ENZYME ACTIVATION; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; HUMANS; INTEGRINS; LUNG NEOPLASMS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84891352194     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv131     Document Type: Erratum

References (49)

1. Herbst,R.S. et al. (2008) Lung cancer. N. Engl. J. Med., 359, 1367-1380.
2. De Wever,O. et al. (2003) Role of tissue stroma in cancer cell invasion. J. Pathol., 200, 429-447.
3. Duffy,M.J. et al. (2008) Cancer invasion and metastasis: changing views. J. Pathol., 214, 283-293.
4. Hugo,H. et al. (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell. Physiol., 213, 374-383.
5. Thiery,J.P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol., 15, 740-746.
6. De Wever,O. et al. (2008) Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer, 123, 2229-2238.
7. Wernert,N. (1997) The multiple roles of tumour stroma. Virchows Arch., 430, 433-443.
8. Pupa,S.M. et al. (2002) New insights into the role of extracellular matrix during tumor onset and progression. J. Cell. Physiol., 192, 259-267.
9. Lunt,S.J. et al. (2009) The tumor microenvironment and metastatic disease. Clin. Exp. Metastasis, 26, 19-34.
10. Ryu,S. et al. (1999) Strong intracellular and negative peripheral expression of fibronectin in tumor cells contribute to invasion and metastasis in papillary thyroid carcinoma. Cancer Lett., 146, 103-109.
11. Labat-Robert,J. (2002) Fibronectin in malignancy. Semin. Cancer Biol., 12, 187-195.
12. Moro,L. et al. (1992) Study of fibronectin and mRNA in human laryngeal and ectocervical carcinomas by in situ hybridization and image analysis. Int. J. Cancer, 51, 692-697.
13. Han,S. et al. (2006) Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/ S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer Res., 66, 315-323.
14. Han,S. et al. (2005) Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett., 219, 71-81.
15. Harima,A. et al. (2008) Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5. Hematology, 13, 236-243.
16. Kaspar,M. et al. (2006) Fibronectin as target for tumor therapy. Int. J. Cancer, 118, 1331-1339.
17. Romberger,D.J. (1997) Fibronectin. Int. J. Biochem. Cell Biol., 29, 939-943.
18. Leiss,M. et al. (2008) The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr. Opin. Cell Biol., 20, 502-507.
19. Pankov,R. et al. (2002) Fibronectin at a glance. J. Cell. Sci., 115(Pt 20), 3861-3863.
20. Astrof,S. et al. (2007) Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev. Biol., 311, 11-24.
21. Grinnell,F. (1984) Fibronectin and wound healing. J. Cell. Biochem., 26, 107-116.
22. Manabe,R. et al. (1997) Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J. Cell Biol., 139, 295-307.
23. Liao,Y.F. et al. (2002) The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J. Biol. Chem., 277, 14467-14474.
24. Shinde,A.V. et al. (2008) Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin alpha9beta1- dependent cellular activities. J. Biol. Chem., 283, 2858-2870.
25. Ramirez,A.M. et al. (2006) Myofibroblast transdifferentiation in obliterative bronchiolitis: tgf-beta signaling through smad3-dependent and -independent pathways. Am. J. Transplant., 6, 2080-2088.
26. Han,S. et al. (2007) Extracellular matrix fibronectin increases prostaglandin E2 receptor subtype EP4 in lung carcinoma cells through multiple signaling pathways: the role of AP-2. J. Biol. Chem., 282, 7961-7972.
27. Muro,A.F. et al. (2008) An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 177, 638-645.
28. White,E.S. et al. (2003) Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am. J. Respir. Crit. Care Med., 168, 436-442.
29. Han,S.W. et al. (2006) Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B. Oncogene, 25, 4341-4349.
30. Stoker,M. et al. (1985) An epithelial scatter factor released by embryo fibroblasts. J. Cell. Sci., 77, 209-223.
31. Cannito,S. et al. (2008) Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis, 29, 2267-2278.
32. Yang,J. et al. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 14, 818-829.
33. Bhowmick,N.A. et al. (2004) Stromal fibroblasts in cancer initiation and progression. Nature, 432, 332-337.
34. Burnham,E.L. et al. (2007) Increased fibronectin expression in lung in the setting of chronic alcohol abuse. Alcohol. Clin. Exp. Res., 31, 675-683.
35. Roman,J. et al. (2004) Nicotine and fibronectin expression in lung fibroblasts: implications for tobacco-related lung tissue remodeling. FASEB J., 18, 1436-1438.
36. Higgins,D.F. et al. (2008) Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle, 7, 1128-1132.
37. White,E.S. et al. (2008) New insights into form and function of fibronectin splice variants. J. Pathol., 216, 1-14.
38. Arai,H. et al. (1997) Loss of EDB+ fibronectin isoform is associated with differentiation of alveolar epithelial cells in human fetal lung. Am. J. Pathol., 151, 403-412.
39. Matsumoto,E. et al. (1999) Expression of fibronectin isoforms in human breast tissue: production of extra domain A+/extra domain B+ by cancer cells and extra domain A+ by stromal cells. Jpn. J. Cancer Res., 90, 320-325.
40. Menrad,A. et al. (2005) ED-B fibronectin as a target for antibody-based cancer treatments. Expert Opin. Ther. Targets, 9, 491-500.
41. Hong,K.O. et al. (2009) Inhibition of Akt activity induces the mesenchymal- to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. J. Exp. Clin. Cancer Res., 28, 28.
42. Strippoli,R. et al. (2008) Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis. Model. Mech., 1, 264-274.
43. Humphries,M.J. (2000) Integrin structure. Biochem. Soc. Trans., 28, 311-339.
44. Takagi,J. et al. (2003) Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J., 22, 4607-4615.
45. Ritzenthaler,J.D. et al. (2008) Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling. Mol. Biosyst., 4, 1160-1169.
46. Gupta,S.K. et al. (2009) Integrin alpha9beta1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase. J. Cell. Sci., 122(Pt 12), 2043-2054.
47. Singh,P. et al. (2009) Loss of integrin alpha9beta1 results in defects in proliferation, causing poor re-epithelialization during cutaneous wound healing. J. Invest. Dermatol., 129, 217-228.
48. Hibi,K. et al. (1994) Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer. Oncogene, 9, 611-619.
49. Singh,P. et al. (2004) The spatial and temporal expression patterns of integrin alpha9beta1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing. J. Invest. Dermatol., 123, 1176-1181.